News | Pulmonary Embolism | March 04, 2019

Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool

Aidoc’s solution flags and prioritizes pulmonary embolisms found in CT pulmonary angiograms

Aidoc Announces CE Mark for AI-based Pulmonary Embolism Workflow Tool

March 4, 2019 — Artificial intelligence (AI) radiology solution provider Aidoc announced the commercial release of its CE-marked product for the identification and triage of pulmonary embolism (PE) in computed tomography (CT) pulmonary angiograms. By flagging obstructions in blood-flow to the lungs, Aidoc prioritizes radiologists’ work queues and helps them detect critical conditions faster, leading to quicker treatment and saving lives.

In the United States alone, up to 600,000 people are diagnosed with PE annually and it is estimated to be responsible for 100,000 annual deaths, making it the third most common cause of cardiovascular death. PE diagnosis can be highly challenging due to its variable and non-specific presentation, making the case that it can truly benefit from AI-driven workflow triage.

At the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, Aidoc ]demonstrated its suite of AI-based workflow solutions. The diagnostic performance of Aidoc’s PE solution at the University Hospital of Basel was presented as part of the ECR scientific sessions, demonstrating research concluding that Aidoc can complement conventional workflows with worklist prioritization and has the potential to improve the quality of healthcare by accelerating the diagnostic process and communication.

Read the abstract and watch the recorded ECR presentation here.

For more information: www.aidoc.com


Related Content

News | Pulmonary Embolism

January 29, 2024 — In patients who undergo pulmonary resection for lung cancer, a major potential postoperative ...

Home January 29, 2024
Home
News | Pulmonary Embolism

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...

Home October 25, 2023
Home
News | Pulmonary Embolism

June 30, 2023 — Of approximately 250,000 Americans diagnosed with acute pulmonary embolism, or PE, in emergency ...

Home June 30, 2023
Home
News | Pulmonary Embolism

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home March 10, 2023
Home
News | Pulmonary Embolism

February 22, 2023 — RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and ...

Home February 22, 2023
Home
News | Pulmonary Embolism

November 17, 2022 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced the ...

Home November 17, 2022
Home
News | Pulmonary Embolism
February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a ...
Home February 16, 2022
Home
News | Pulmonary Embolism

February 14, 2022 — Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the ...

Home February 14, 2022
Home
News | Pulmonary Embolism

August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...

Home August 09, 2021
Home
News | Pulmonary Embolism

October 23, 2020 — Positive results were reported on the first 230 patients enrolled in its FLASH study, a real world ...

Home October 23, 2020
Home
Subscribe Now